Shenzhen Lifotronic Technology Co., Ltd. (SHA:688389)
12.23
-0.09 (-0.73%)
May 21, 2026, 3:00 PM CST
SHA:688389 Revenue
Shenzhen Lifotronic Technology had revenue of 259.96M CNY in the quarter ending March 31, 2026, with 20.94% growth. This brings the company's revenue in the last twelve months to 1.08B, up 2.42% year-over-year. In the year 2025, Shenzhen Lifotronic Technology had annual revenue of 1.04B, down -9.60%.
Revenue (ttm)
1.08B
Revenue Growth
+2.42%
P/S Ratio
4.84
Revenue / Employee
616.65K
Employees
1,756
Market Cap
5.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.04B | -110.21M | -9.60% |
| Dec 31, 2024 | 1.15B | 2.32M | 0.20% |
| Dec 31, 2023 | 1.15B | 162.67M | 16.55% |
| Dec 31, 2022 | 983.04M | 204.94M | 26.34% |
| Dec 31, 2021 | 778.11M | 224.28M | 40.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GKHT Medical Technology | 6.82B |
| Guangdong Biolight Meditech | 1.10B |
| Getein Biotech | 1.08B |
| Zhejiang Orient Gene Biotech | 1.01B |
| Shanghai Kinetic Medical | 869.21M |
| Shanghai Aohua Photoelectricity Endoscope | 787.64M |
| Hangzhou AGS MedTech | 609.05M |
| Shanghai Sanyou Medical | 549.93M |